American Vietnamese Biotech Incorporation (HNX:AMV) announced a private placement of 37,962,045 common shares at a price of VND 10,000 per share for gross proceeds of VND 379,620,450,000 on March 1, 2021. The transaction will involve participation from returning individual investors, Nguyen Thi Hong Hai for 8,000,000 shares, Nguyen Hoan Thien for 5,000,000 shares, Dang Nhi Nuong for 5,000,000 shares, and new investors, Lotus Investment Management Joint Stock Company for 4,000,000 shares, Nguyen Thi Hien for 4,800,000 shares, Ngo Van Binh for 5,962,045 shares, and Nguyen Mai Loan for 5, 200,000 shares. Post completion of the transaction, Nguyen Thi Hong Hai, Nguyen Hoan Thien, and Dang Nhi Nuong owns 8,000,028 shares, 5,124,320 shares, and 11,194,076 shares respectively in the company and Nguyen Thi Hong Hai, Nguyen Hoan Thien, Nguyen Thi Hien, Dang Nhi Nuong, Ngo Van Binh, Lotus Investment Management Joint Stock Company, and Nguyen Mai Loan owns 8.78%, 5.62%, 5.27%, 12.29%, 6.54%, 4.39%, and 5.71% stake respectively in the company. The company paid VND 110,000,000 as consulting expenses with respect to the transaction.